Author： Lea R. Whorwell P.J.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.19, Iss.6, 2001-06, pp. : 643-653
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
By Akehurst R.L. Brazier J.E. Mathers N. O'Keefe C. Kaltenthaler E. Morgan A. Platts M. Walters S.J.
PharmacoEconomics, Vol. 20, Iss. 7, 2002-01 ,pp. :
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :
Clinical Drug Investigation, Vol. 27, Iss. 1, 2007-01 ,pp. :
Serotonergic modulation and irritable bowel syndrome
By Borman R.
Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. :